Details
| Stereochemistry | MIXED |
| Molecular Formula | C18H33FO2 |
| Molecular Weight | 299.4544 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 2 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCC([18F])CCCC[C@@H]1C[C@H]1CC(O)=O
InChI
InChIKey=DDTRZLZETKPBPQ-YWWFHXEUSA-N
InChI=1S/C18H33FO2/c1-2-3-4-5-6-7-11-17(19)12-9-8-10-15-13-16(15)14-18(20)21/h15-17H,2-14H2,1H3,(H,20,21)/t15-,16+,17?/m1/s1/i19-1
| Molecular Formula | C18H33FO2 |
| Molecular Weight | 299.4544 |
| Charge | 0 |
| Count |
|
| Stereochemistry | EPIMERIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 3 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Tue Apr 01 18:07:49 GMT 2025
by
admin
on
Tue Apr 01 18:07:49 GMT 2025
|
| Record UNII |
FDG79C95XB
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
FDG79C95XB
Created by
admin on Tue Apr 01 18:07:49 GMT 2025 , Edited by admin on Tue Apr 01 18:07:49 GMT 2025
|
PRIMARY | |||
|
300000042511
Created by
admin on Tue Apr 01 18:07:49 GMT 2025 , Edited by admin on Tue Apr 01 18:07:49 GMT 2025
|
PRIMARY | |||
|
855927-17-2
Created by
admin on Tue Apr 01 18:07:49 GMT 2025 , Edited by admin on Tue Apr 01 18:07:49 GMT 2025
|
PRIMARY | |||
|
CARDIOPET
Created by
admin on Tue Apr 01 18:07:49 GMT 2025 , Edited by admin on Tue Apr 01 18:07:49 GMT 2025
|
PRIMARY | CardioPET is: An F-18 labeled, modified fatty acid that provides insight into regions with decreased blood flow or metabolic insufficiency in the myocardium.; CardioPET may be used to: Identify patients that will benefit from PCI or revascularization and guide intervention, Assess myocardial viability, Evaluate CAD in patients that cannot exercise.; Agent: Muscle State Imaging Agent, Type: Fatty Acid (Labeled with Fluorine 18), Condition: Coronary Artery Disease, Status: completed enrollment.;This imaging agent exploits the dietary needs of the heart as it relates to glucose and fatty acids. By introducing a radio-labeled analog to the natural fatty acids utilized as an energy source by the heart we can visualize the anatomic location and state of the muscle within the areas defined by the specific coronary artery blood flow distribution and detect problems in advance of symptoms that would lead to a stress test. | ||
|
24824703
Created by
admin on Tue Apr 01 18:07:49 GMT 2025 , Edited by admin on Tue Apr 01 18:07:49 GMT 2025
|
PRIMARY | |||
|
13301
Created by
admin on Tue Apr 01 18:07:49 GMT 2025 , Edited by admin on Tue Apr 01 18:07:49 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
imaging agent
CardioPET is: An F-18 labeled, modified fatty acid that provides insight into regions with decreased blood flow or metabolic insufficiency in the myocardium.; CardioPET may be used to: Identify patients that will benefit from PCI or revascularization and guide intervention, Assess myocardial viability, Evaluate CAD in patients that cannot exercise
|
